Steven M. Lutz

Steven M. Lutz

Verkoop & Marketing bij NEOS THERAPEUTICS, INC.

57 jaar
Health Technology
Consumer Services

Profiel

Steven M.
Lutz
was the founder of Cornerstone Therapeutics, Inc. (founded in 2008) where he held the title of Executive Vice President-Manufacturing & Trade from 2008 to 2011.
He is currently the Vice President-Trade Sales at Neos Therapeutics, Inc. Mr. Lutz's former positions included being the President & Chief Executive Officer of Praelia Pharmaceuticals, Inc. from 2011 to 2014, Executive Vice President-Manufacturing & Trade at Cornerstone BioPharma, Inc. from 2004 to 2008, National Account Manager at Biovail Pharmaceuticals LLC in 2001 to 2002, Executive Vice President-Operations at Cornerstone Therapeutics, Inc., Vice President-Corporate Accounts at Carolina Pharmaceuticals, Inc. from 2003 to 2004, and President of Aristos Pharmaceuticals, Inc. from 2003 to 2011.
Mr. Lutz received his undergraduate degree from Moravian College.

Actieve functies van Steven M. Lutz

Eerdere bekende functies van Steven M. Lutz

BedrijvenFunctieEinde
Praelia Pharmaceuticals, Inc. Algemeen Directeur 01-03-2014
CORNERSTONE THERAPEUTICS, INC. Oprichter 30-09-2011
President 01-09-2011
Corporate Officer/Principal 04-11-2008
Carolina Pharmaceuticals, Inc. Corporate Officer/Principal 01-08-2004
Ervaring van Steven M. Lutz in detail bekijken

Opleiding van Steven M. Lutz

Moravian College Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Steven M. Lutz in detail bekijken

Connecties

26

Eerstegraads connecties

8

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit7

Health Technology

Health Technology

Health Technology

Health Technology

Carolina Pharmaceuticals, Inc.

Health Technology

Praelia Pharmaceuticals, Inc.

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Steven M. Lutz
-40 % Uitzonderlijk verlengd: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU